Table 1. Clinical and laboratory data from ITP patients.
| Patient | Platelets | Auto-antibody directed to: | BS | Treatment | ||
|---|---|---|---|---|---|---|
| N° | (x 109/L) | GPIIbIIIa | GPIbIX | GPIaIIa | ||
| 1 | 38 | - | - | - | 2 | None |
| 2 | 30 | - | - | - | 1 | Corticosteroids |
| 3 | 52 | - | - | + | 2 | None / Spl. |
| 4 | 85 | - | - | - | 0 | Danazol |
| 5 | 46 | - | - | - | 2 | None / Spl. |
| 6 | 6 | + | - | - | 2 | None |
| 7 | 30 | - | - | - | 1 | Corticosteroids |
| 8 | 16 | - | + | - | 2 | Corticosteroids/Spl. |
| 9 | 29 | - | - | - | 2 | Corticosteroids/Spl |
| 10 | 50 | + | - | - | 1 | Corticosteroids |
| 11 | 30 | - | - | - | 1 | None |
| 12 | 22 | - | - | - | 2 | Cortic/IVIg/Spl |
| 13 | 63 | - | - | - | 2 | Corticosteroids |
| 14 | 8 | - | - | - | 2 | None / Spl. |
| 15 | 65 | - | - | - | 0 | Corticosteroids |
| 16 | 22 | - | - | - | 2 | Corticosteroids |
| 17 | 20 | - | - | - | 0 | None |
| 18 | 62 | - | - | - | 2 | Corticosteroids |
| 19 | 50 | + | - | - | 1 | None |
| 20 | 53 | + | - | + | 1 | Corticosteroids |
| 21 | 37 | - | - | - | 2 | Corticosteroids |
| 22 | 50 | ND | ND | ND | 1 | None |
| 23 | 23 | ND | ND | ND | 1 | None |
| 24 | 40 | + | - | - | 2 | Azathioprine/Spl. |
Platelet count and treatment at the time of study. BS: Bleeding scale; Spl: splenectomy; Cortic: Corticosteroids; IVIg: intravenous immunoglobulin; ND: not done.